chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.02
Sex: F
Vaccine: PNC, VARCEL
Symptoms: Cellulitis, Induration, Injection site erythema, Injection site rash, Rash erythematous
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old female who on 30-APR-2009 was vaccinated with the first dose of VARIVAX (lot # 663802/0160Y). Concomitant therapy included a dose of PREVNAR given on the same day. On 11-MAY-2009,  "eleven days later", there was a red rash at the injection site that went from a bump to a red patch (The onset date was reported as 30-APR-2009). On 14-MAY-2009, "three days later", the bump was hard and red with no discharge. The patient came into the office and was diagnosed with cellulitis and was positive for rhinorrhea. The patient was given AUGMENTIN to treat the symptoms. At the time of this report, the outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 1.02
Sex: F
Vaccine: PNC, VARCEL
Symptoms: Rhinorrhoea
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old female who on 30-APR-2009 was vaccinated with the first dose of VARIVAX (lot # 663802/0160Y). Concomitant therapy included a dose of PREVNAR given on the same day. On 11-MAY-2009,  "eleven days later", there was a red rash at the injection site that went from a bump to a red patch (The onset date was reported as 30-APR-2009). On 14-MAY-2009, "three days later", the bump was hard and red with no discharge. The patient came into the office and was diagnosed with cellulitis and was positive for rhinorrhea. The patient was given AUGMENTIN to treat the symptoms. At the time of this report, the outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 40.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Dysphagia, Measles antibody negative, Oropharyngeal pain, Pain
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 40 year old female with hypothyroidism, hypercholesterolaemia and drug reactions/allergies to codeine and COMPAZINE. On 18-NOV-2008 the lab test results revealed varicella titer was 0.82 and rubeola titer was negative. On 22-MAY-2009 the patient was vaccinated SC with a 0.5 ml dose of VARIVAX (Merck) (lot # 658967/1521U) in the right arm. Concomitant suspect therapy included a dose of MMR II (rHA) (lot # 663106/1507X) given in the left arm on the same day. Other concomitant therapy included oral contraceptive, ALIGN, thyroid medication, pravastatin Na, LEXAPRO, vitamin B complex and ESTER-C. Prior to receiving the vaccines she complained of a low grade of fever, allergies and a sore throat. The nurse reported that the patient developed lesions in her throat after vaccination. On 26-May-2009, "four days after receiving the vaccines", the patient experienced a fever of 100F-101F, sore throat, difficulty swallowing and achiness. She was examined in the office by her physician who reported she had pharyngeal lesions. Unspecified medical attention was sought. At the time of this report, the patient's symptoms persisted. Follow-up information received from another registered nurse (R.N.) reported the 40 year old female with hypothyroidism, hypercholesterolaemia and seasonal/environmental allergies and sore throat at time of vaccination. On 22-MAY-2009 the patient was vaccinated SC with the first 0.5 ml dose of VARIVAX (Merck) (lot # 658967/1521U) in the right arm. Concomitant suspect therapy included the first dose of MMR II (rHA) (lot # 663106/1507X) given in the left arm on the same day. On 24-MAY-2009 the patient complained with a sore throat. On 26-MAY-2009 she had a fever of 100.6 F and sore throat. She was evaluated by her physician. On approximately 29-MAY-2009 she developed lesions in her throat and mouth. She also had a small amount of lesions around the injection site. It was reported that on 01-JUN-2009 the patient recovered from these events. Additional information is not expected.
Age: 40.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pharyngeal lesion, Pyrexia, Throat lesion, Varicella virus test positive
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 40 year old female with hypothyroidism, hypercholesterolaemia and drug reactions/allergies to codeine and COMPAZINE. On 18-NOV-2008 the lab test results revealed varicella titer was 0.82 and rubeola titer was negative. On 22-MAY-2009 the patient was vaccinated SC with a 0.5 ml dose of VARIVAX (Merck) (lot # 658967/1521U) in the right arm. Concomitant suspect therapy included a dose of MMR II (rHA) (lot # 663106/1507X) given in the left arm on the same day. Other concomitant therapy included oral contraceptive, ALIGN, thyroid medication, pravastatin Na, LEXAPRO, vitamin B complex and ESTER-C. Prior to receiving the vaccines she complained of a low grade of fever, allergies and a sore throat. The nurse reported that the patient developed lesions in her throat after vaccination. On 26-May-2009, "four days after receiving the vaccines", the patient experienced a fever of 100F-101F, sore throat, difficulty swallowing and achiness. She was examined in the office by her physician who reported she had pharyngeal lesions. Unspecified medical attention was sought. At the time of this report, the patient's symptoms persisted. Follow-up information received from another registered nurse (R.N.) reported the 40 year old female with hypothyroidism, hypercholesterolaemia and seasonal/environmental allergies and sore throat at time of vaccination. On 22-MAY-2009 the patient was vaccinated SC with the first 0.5 ml dose of VARIVAX (Merck) (lot # 658967/1521U) in the right arm. Concomitant suspect therapy included the first dose of MMR II (rHA) (lot # 663106/1507X) given in the left arm on the same day. On 24-MAY-2009 the patient complained with a sore throat. On 26-MAY-2009 she had a fever of 100.6 F and sore throat. She was evaluated by her physician. On approximately 29-MAY-2009 she developed lesions in her throat and mouth. She also had a small amount of lesions around the injection site. It was reported that on 01-JUN-2009 the patient recovered from these events. Additional information is not expected.
Age: 15.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse concerning a 15 year old male with no specified drug reactions/allergies or medical history, on an unspecified day in 1998 was vaccinated with VARIVAX (Merck) (dose, route and lot number unspecified). The nurse reported "the patient developed a mild case of chicken pox (amount of lesions was unknown) last week (approximately on 22-MAY-2009). At the time of the report the outcome of the patient was unspecified. The patient sought medical attention at the physician's office. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 4 year old male patient who in 2006 was vaccinated with VARIVAX (Merck). The patient developed a mild case of chickenpox (amount of lesions was unknown) last week in May 2009. The patient had sought physician for medical attention. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: Information has been received from a healthcare worker concerning a 12 month old female patient who on 01-MAY-2009 was vaccinated with the first dose of VARIVAX (lot # 663819/0336Y). After vaccination on the same day the patient experienced injection site reaction with swelling and redness. The patient was diagnosed with "severe cellulitis and was treated". The patient had sought medical attention via office visit and recovered now. This is one of several reports received from the same source. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Injection site swelling
Clinical narrative: Information has been received from a healthcare worker concerning a 12 month old male who on 04-MAY-2009 was vaccinated with VARIVAX (Merck) (lot# 663819/0336Y, subcutaneous injection, dose and site of administration not reported). On 04-MAY-2009 the patient had an injection site reaction, which included had swelling, redness and induration at the injection site after VARIVAX (Merck) was given. The patient visited the office for some unspecified medical attention. Subsequently, the patient recovered from injection site reaction on an unknown date. This is one of several cases from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU(H1N1), MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Tenderness, redness, swelling.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Pain, Swelling
Clinical narrative: Td/Tdap VIS 11/18/08 was given to parent/guardian or patient. (hmf16) _05.17.10 13:46 TC from pt. ID verified. Pt states she has swelling and pain in her L armpit. Pt states she had swelling there before due to excess breast tissue and had that removed. Advised pt to f/u PF this afternoon for physician evaluation. Pt voiced understanding.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes virus infection, Laboratory test normal, Oropharyngeal pain
Clinical narrative: Sore throat started night of having vaccinated treated it like a cold. No other signs of cold or symptoms a week later. Allergist concluded since lab results were negative for staph or bacterial-treat patient for herpes viral with acyclovir. Tx was successful.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Disability, Guillain-Barre syndrome, Immunoglobulin therapy
Clinical narrative: Information has been received from a physician and healthcare worker concerning a 4 year old male with no allergy who on an unspecified date was vaccinated with the first dose of VARIVAX (Merck) (LOT# not reported). Second suspect vaccine included MMR II (Lot # not reported). Other concomitant therapy included ZYRTEC. The physician and healthcare worker reported that the patient experienced Guillain Barre Syndrome. The patient was hospitalized and received a treatment of IV IG (immune globulin) for five days for Guillain Barre on 02-JUN-2009. The physician felt that Guillain Barre Syndrome was not related to vaccinations but was caused by a virus. At the time of this report the patient had not recovered. The patient was hospitalized. The physician felt the Guillain Barre Syndrome was an other important medical event. Follow-up information has been received from the physician who indicated that the patient (was new to their practice 14-JUL-2009, birth weight 7 lb 4 oz., 2 siblings) who on 02-JUN-2009 was diagnosed with Guillain Barre Syndrome in the hospital. The patient received a treatment of IV IG (immune globulin) for six days (also reported as five days). Subsequently, the patient was undergoing physical therapy. Subsequent vaccine update the MMR II, VARICELLA (Merck), IPV (unspecified) and Tdap were to delayed three months after immune globulin (IVIG) as per the Center for Disease Control (CDC). The patient was hospitalized for 6 days. The physician considered the Guillain Barre Syndrome to be disabling. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Pneumonia
Clinical narrative: Information has been received from a pharmacy intern concerning her co-worker's grandson, a 4 year old male with no pertinent medication history who on 01-DEC-2005 was vaccinated with the first dose of VARIVAX (Merck) (Lot # was not provided). Concomitant therapy included MMR II and POLIO (unspecified). No lab diagnostics studies performed. In March 2006, the patient developed pneumonia and was admitted into hospital. The patient was in the hospital for three days and released. However, one week later, the patient developed shingles. After the recovery, the patient later received the second dose of VARIVAX (Merck). Follow-up information has been received from the physician concerning the patient who last visited the physician' office on 20-FEB-2006. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient who in November 2008, was vaccinated subcutaneously with a 0.5 mL dose of VARIVAX (Merck).  The patient mistakenly was given a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck).  The reporter had no information on whether this was product confusion or staff error.  No adverse effect was reported.  Additional information has been requested.
Age: 53.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from an office manager concerning a 53 year old physician who on 02-JUN-2009 was intended to receive ZOSTAVAX (Merck) was inadvertently administered with VARIVAX (Merck) due to a human error. No adverse effect reported. It's unknown if the patient had sought any medical attention. Follow up information had received from the office manager indicated that the patient received VARIVAX (Merck) (lot # 663301/1776X) exp 11-DEC-2010 on 02-JUN-2009. The patient was alive and well and experienced no side effects. This is one of several reports from the same source. Additional information has been requested.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 9 year old female patient who on an unspecified date, the patient had a severe case of varicella. The patient sought unspecified medical attention. On an unspecified date, the patient recovered. Additional information has been requested.
Age: 33.0
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Drug exposure during pregnancy, Inappropriate schedule of drug administration, Injection site pain, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a 33 year old female consumer for the pregnancy registry for VARIVAX (Merck) concerning herself with no known drug allergies/drug reactions who on 06-MAY-2009 was vaccinated with the first 0.5 mL dose of VARIVAX (Merck). Secondary suspect vaccine included MMR II (MSD). Other concomitant vaccine included DTAP (manufacturer unknown). It was reported that the patient experienced pain at the injection site after getting VARIVAX (Merck), MMR II and DTAP. It was also reported that as of 04-JUN-2009 the patient was seven weeks pregnant. The patient sought unspecified medical attention. The last menstrual period was the "second or third week of April 2009" and the estimated delivery date was on 12-JAN-2010. No further information is available.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old patient who on 04-JUN-2009 was vaccinated with the second dose of VARIVAX (lot# 662576/0046Y, route and site of administration not reported). 48 hours later the patient developed blister around the injection site where the second dose of VARIVAX was given. It was reported that there were also blisters located on the "left upper arm" and "covered more than on dermatone". The nurse stated the physician reported the blisters as "not typical of varicella. Unspecified medical attention was sought by the patient. The patient's outcome was unknown. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Fall, Immediate post-injection reaction, Loss of consciousness, Nasal oedema, Syncope
Clinical narrative: Information has been received from a Physician Assistant concerning a 12 year old female with unknown drug allergies and unknown medical history who on 04-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) (lot #662473/0044Y).  Concomitant therapy included MENACTRA.  On 04-JUN-2009, the patient passed out after receiving the second dose of VARIVAX (Merck) (lot # 662473/0044Y).  He fell forward in the chair and hit her face on the floor.  Unspecified medical attention was sought and facial bone X-ray was performed.  The X-ray of the patient's face showed there were no broken bones.  At the time of the report, the patient had recovered on 04-JUN-2009.  Follow up information was received from a Physician Assistant concerning that a 14 years old female with Rhunt allergy and no illness at the time of vaccination who on 05-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) (lot #662473/0044Y) intramuscularly in the left deltoid region at 10:30 am.  She received the first dose of VARIVAX (Merck) on 08-DEC-1997.  Concomitant therapy included the first dose of MENACTRA (lot # 62917AA, Sanofi Pasteur) at 10:30 am on 05-JUN-2009.  The patient had syncopal episode immediately following vaccination.  She smashed her face off a stool in the treatment room and had immediate swelling of her nose.  But the facial bone X-ray was performed, with negative result.  Unspecified medical attention was sought.  On 05-JUN-2009, the patient recovered.  No further information is available.
Age: 14.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: X-ray normal
Clinical narrative: Information has been received from a Physician Assistant concerning a 12 year old female with unknown drug allergies and unknown medical history who on 04-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) (lot #662473/0044Y).  Concomitant therapy included MENACTRA.  On 04-JUN-2009, the patient passed out after receiving the second dose of VARIVAX (Merck) (lot # 662473/0044Y).  He fell forward in the chair and hit her face on the floor.  Unspecified medical attention was sought and facial bone X-ray was performed.  The X-ray of the patient's face showed there were no broken bones.  At the time of the report, the patient had recovered on 04-JUN-2009.  Follow up information was received from a Physician Assistant concerning that a 14 years old female with Rhunt allergy and no illness at the time of vaccination who on 05-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) (lot #662473/0044Y) intramuscularly in the left deltoid region at 10:30 am.  She received the first dose of VARIVAX (Merck) on 08-DEC-1997.  Concomitant therapy included the first dose of MENACTRA (lot # 62917AA, Sanofi Pasteur) at 10:30 am on 05-JUN-2009.  The patient had syncopal episode immediately following vaccination.  She smashed her face off a stool in the treatment room and had immediate swelling of her nose.  But the facial bone X-ray was performed, with negative result.  Unspecified medical attention was sought.  On 05-JUN-2009, the patient recovered.  No further information is available.
Age: 0.96
Sex: F
Vaccine: VARCEL
Symptoms: Arthralgia, Blister, Blood urine present, Henoch-Schonlein purpura, Oedema
Clinical narrative: Information has been received from a Registered Nurse concerning her 12 year old daughter with no pertinent medical history and no known drug allergies/drug reactions, who on an unspecified date, when she was 1 year old, was vaccinated with a dose of VARIVAX (Merck). There was no concomitant therapy reported. It was reported that soon after administration of VARIVAX (Merck) the patient developed a mild case of varicella. She mostly had lesions on her face and some scattered on her abdomen. It was reported that the patient also had fever. The patient sought unspecified medical attention. There were no laboratory diagnostic tests performed. It was reported that on an unspecified date the patient had recovered. It was reported that on an unspecified date when she was 5 years of age, the patient also developed Henoch Schonlein syndrome after administration of unspecified vaccines. The patient developed edema and pain in both her ankles. The patient also had blood in her urine and later she developed blister like lesions on both her legs. The patient was hospitalized overnight (unspecified hospital). No further information is available.
Age: 0.96
Sex: F
Vaccine: VARCEL
Symptoms: Oedema peripheral, Pyrexia, Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a Registered Nurse concerning her 12 year old daughter with no pertinent medical history and no known drug allergies/drug reactions, who on an unspecified date, when she was 1 year old, was vaccinated with a dose of VARIVAX (Merck). There was no concomitant therapy reported. It was reported that soon after administration of VARIVAX (Merck) the patient developed a mild case of varicella. She mostly had lesions on her face and some scattered on her abdomen. It was reported that the patient also had fever. The patient sought unspecified medical attention. There were no laboratory diagnostic tests performed. It was reported that on an unspecified date the patient had recovered. It was reported that on an unspecified date when she was 5 years of age, the patient also developed Henoch Schonlein syndrome after administration of unspecified vaccines. The patient developed edema and pain in both her ankles. The patient also had blood in her urine and later she developed blister like lesions on both her legs. The patient was hospitalized overnight (unspecified hospital). No further information is available.
Age: 13.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 13 year old female who on 19-MAY-2009 was vaccinated SQ with a second 0.5 mL dose of VARIVAX (lot # not reported). It was reported that the patient's arm was very red and swollen and sore at the injection site. On an unspecified date the patient had recovered. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Foetal disorder, Ultrasound scan abnormal
Clinical narrative: Information has been received from a physician for the pregnancy registry for GARDASIL concerning a female baby. The baby's 32 year old mother with 1 previous pregnancy and 1 full term delivery who on 21-APR-2009 was vaccinated with SQ with her first 0.5 ml dose of VARIVAX. Concomitantly therapy included prenatal vitamins. Subsequently, the baby's mother was pregnant. Date of last menstrual period was 23-APR-2009 and her estimated delivery date was 28-JAN-2010. At 20 weeks from LMP, on approximately 10-SEP-2009, the ultrasound was performed and it showed a mild fetal pyelectasia. On unspecified date, the mild fetal pyelectasia was resolved. On 08-JAN-2010, the mother delivered the normal female baby, weighing 5 pounds, 4 ounces. The mother's experience had been captured in WAES #0906USA01405. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a medical assistant concerning a patient who was vaccinated with VARIVAX (Merck) instead of ZOSTAVAX (Merck) by mistake due to an office error. No adverse reactions reported. It's unknown if the patient had sought any medical attention. Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site cellulitis, Injection site induration, Injection site pruritus, Injection site swelling, Skin discolouration
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old female patient with otitis media who on 12-MAY-2009 was vaccinated with VARIVAX (Merck). Concomitant therapy included OMNICEF and ZITHROMAX. On 01-JUN-2009 the patient experienced a raised induration on her right thigh that was pink and purple. The patient was treated for an ear infection at the time of vaccination. The nurse prescribed AUGMENTIN to treat the induration. The nurse later reported that the patient had cellulitis after receiving VARIVAX (Merck). The patient had not recovered at the time of reporting. Unspecified medical attention had been sought. Follow up information has been received from the registered nurse indicated that their practice has recently seen 5 cases of cellulitis with VARIVAX (Merck). One case was this report which the office feels may have been an allergic reaction. The site was itchy and 13cm of involvement. No specific lot check because the cases were different lot numbers (exact numbers unspecified) but all were single dose vials received after the recent backorder. Different nurses, facilities and circumstances and office never had cellulitis cases like this before. Follow up information has been received from the registered nurse concerning the 12 month old female patient who on 12-MAY-2009 was vaccinated with the first dose of VARIVAX (Merck) on the right thigh and the first dose of MMR II (MSD) on the left thigh. The patient was well at the time of vaccination. Patient came in office two weeks after vaccine with 1/2 inch induration (right thigh) that was pink-purple and started on 12-MAY-2009. The patient was prescribed AUGMENTIN for 10 days. The patient had recovered on 11-JUN-2009. This is one of several reports from the same source. No further information is available.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a currently 6 year old male who in approximately 2004 (at 12 to 15 months old) was vaccinated with the first dose of VARIVAX (Merck) (lot#, route and site of administration not reported). About a month later (at approximately age 13 months) the patient had a breakthrough case of chickenpox with less than 50 lesions on his body. The outcome of the chickenpox was unknown. In approximately 2008 (at five and a half years old) the patient received the second dose of VARIVAX (Merck) (lot#, route and site of administration not reported). About three to four months after vaccination, the patient developed a rash all over his body, but he had no fever. The nurse reported the patient had seen another physician other than the primary care physician and no diagnosis had been made. At the time of reporting the patient still had the rash all over his body and may be going to see a dermatologist. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 77 year old male patient with an unknown history of varicella who was vaccinated with VARIVAX (Merck) instead of ZOSTAVAX (Merck) due to an office error. No adverse reactions reported. It's unknown if the patient had sought any medical attention. No further information is available as the nurse does not wish to be contacted.
Age: 14.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Cellulitis, Erythema, Induration, Skin warm, Tenderness
Clinical narrative: Initial and follow up information has been received from a registered nurse concerning a female who was vaccinated with VARIVAX (Merck) (lot #, route and site of administration not reported).  Subsequently the patient developed cellulitis after getting the vaccine.  The outcome of the patient was unknown.  Follow up information has been received from a registered nurse concerning the 14 year old female student with no other relevant history who on 10-JAN-1998 was vaccinated with the first dose of VARIVAX (Merck) (lot #, route and site of administration not reported).  On 25-APR-2009, at 11:30 a.m., the patient was vaccinated subcutaneously with the second dose of VARIVAX (Merck) (lot # 662448/1785X) into the left arm.  On 27-APR-2009 the patient presented to office with 13 X 13cm area at posterior upper arm, red, warm, tender, minimal induration.  There was no lymphangitis.  There was no illness at time of vaccination.  The patient and none of her siblings had no adverse event following prior vaccination.  No relevant diagnostic tests performed.  The patient was prescribed with clindamycin 300, three times a day for 10 days.  On 01-MAY-2009 the patient recovered.  Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Induration, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Initial and follow up information has been received from a registered nurse concerning a female who was vaccinated with VARIVAX (Merck) (lot #, route and site of administration not reported).  Subsequently the patient developed cellulitis after getting the vaccine.  The outcome of the patient was unknown.  Follow up information has been received from a registered nurse concerning the 14 year old female student with no other relevant history who on 10-JAN-1998 was vaccinated with the first dose of VARIVAX (Merck) (lot #, route and site of administration not reported).  On 25-APR-2009, at 11:30 a.m., the patient was vaccinated subcutaneously with the second dose of VARIVAX (Merck) (lot # 662448/1785X) into the left arm.  On 27-APR-2009 the patient presented to office with 13 X 13cm area at posterior upper arm, red, warm, tender, minimal induration.  There was no lymphangitis.  There was no illness at time of vaccination.  The patient and none of her siblings had no adverse event following prior vaccination.  No relevant diagnostic tests performed.  The patient was prescribed with clindamycin 300, three times a day for 10 days.  On 01-MAY-2009 the patient recovered.  Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Cellulitis, Erythema, Induration, Skin warm, Tenderness
Clinical narrative: Information has been received from a health professional concerning a 14 year old female student who on 10-JAN-1998 was vaccinated with her first dose of VARIVAX (Merck) subcutaneously.  There was no concomitant medication.  On 25-APR-2009 she was vaccinated SC in the left arm at 11:30 am with the second dose of VARIVAX (Merck) (Lot # 662448/1785X).  On 27-APR-2009 the patient presented to the doctor's office with a 13 X 13 cm area on the left posterior upper arm that was red, warm and tender.  There was no lymphangitis and minimal induration.   She was treated with clindamycin 300 mg TID for ten days and recovered on 01-MAY-2009.  Subsequently, the patient recovered from red injection site, warm injection site and tender injection site.  No further information is available.
Age: 14.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Induration, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Information has been received from a health professional concerning a 14 year old female student who on 10-JAN-1998 was vaccinated with her first dose of VARIVAX (Merck) subcutaneously.  There was no concomitant medication.  On 25-APR-2009 she was vaccinated SC in the left arm at 11:30 am with the second dose of VARIVAX (Merck) (Lot # 662448/1785X).  On 27-APR-2009 the patient presented to the doctor's office with a 13 X 13 cm area on the left posterior upper arm that was red, warm and tender.  There was no lymphangitis and minimal induration.   She was treated with clindamycin 300 mg TID for ten days and recovered on 01-MAY-2009.  Subsequently, the patient recovered from red injection site, warm injection site and tender injection site.  No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Viral titre decreased
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with two doses of VARIVAX (lot#, route and site of administration not reported). The patient still had a low titer after vacciantion. The physician did not want to answer any questions for the report. No further information is available.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a physician concerning a 10 year old female patient who was vaccinated with the second dose of VARIVAX. Subsequently the patient experienced a localized rash around the injection site. The patient had saw physician for medical attention. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Immediate post-injection reaction, Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a 15 year old female who on 05-JUN-2009 was vaccinated with VARIVAX (Merck) (lot#, route and site of administration not reported). On 05-JUN-2009 the patient developed extremely swollen arm from the shoulder down to the elbow right after getting the vaccine. Unspecified medical attention was sought. At the time of reporting the patient was recovering. This is one of several cases from the same source. Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from an office manager concerning a 52 year old female patient who on 02-JUN-2009 was vaccinated with VARIVAX (Merck) (lot # 663301/1776X) exp 11-DEC-2010 instead of ZOSTAVAX (Merck). The office manager reported it was just human error and could not have been prevented. It's unknown if the patient had sought any medical attention. The patient was alive and well and experienced no side effects. This is one of several reports from the same source. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Immediate post-injection reaction, Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a 11 year old female who on 05-JUN-2009 was vaccinated with VARIVAX (lot#, route and site of administration not reported). Concomitant therapy included Hep B (unspecified) (lot#, route and site of administration not reported) which was also vaccinated on 05-JUN-2009. On 05-JUN-2009 the patient developed extremely swollen arm from the shoulder down to the elbow right after getting the vaccine. Unspecified medical attention was sought. At the time of reporting the patient was recovering. This is one of several cases from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cellulitis, Erythema, Oedema peripheral, Skin warm
Clinical narrative: Information has been received from a doctor's nurse concerning a 4 year old male patient who in 2005 was vaccinated with the first dose of VARIVAX (Merck). Then the patient was given VARIVAX (Merck), MMR II (MSD) (rHA, lot # 659705/0356X), DTAP (lot # C2999AA, manufacturer unknown) and poliovirus vaccine inactivated (VERO) (+) tetanus toxoid (lot # A1229, manufacturer unknown) concomitantly. The VARIVAX (Merck) and DTAP were administered in the patient's left thigh and the MMR II and poliovirus vaccine inactivated (VERO) (+) tetanus toxoid were administered in his right thigh. On 06-JUN-2009, the parents reported that there was "rapidly spreading erythema" on his left thigh. "Eventually it got to 18 centimeters by 9 centimeters." The nurse reported that it was an "Erythematous macular rash, which was warm and slightly indurated, and it was diagnosed as cellulitis secondary to vaccination." The patient was given "DURICES" (Manufacturer unknown) 500mg and BACTROBAN. It's also reported from a field employee that this is the 6th VARIVAX (Merck) AE from this office about for cellulitis. The nurse told that this started happening when they started getting single vials of VARIVAX (Merck) instead of the 10 packs. The a field employee said that his records show that they have not been from the same lot number. Follow up information has been received from the doctor's nurse reported that the 4 year old male patient with no pre-existing allergies, birth defects, or medical conditions who on 04-JUN-2009 was vaccinated with the second dose of VARIVAX (Merck) on the left thigh and the second dose of MMR II on the right thigh. Two days after vaccines, the patient's leg (left thigh) was warm, swollen and had 18 cm x 9.5 cm cellulitis which started on 04-JUN-2009. Subsequently the patient was recovered on approximately 16-JUN-2009. The patient was "well" at the time of vaccination. Additional information is not expected.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a physician concerning a 10 year old male who was recovering from pertussis, with penicillin allergy and sulfonamide allergy and a history of a very severe cellulitis who on 09-JUN-2009 was vaccinated with VARIVAX (Merck) (lot# 664018/0475Y, 0.5ml, subcutaneous injection). Concomitantly, the patient received a tuberculosis skin test. On 10-JUN-2009 the patient developed local injection site reaction after vaccination. The patient had red, swollen, hot, itchy area that covered most of the upper arm. The patient saw the physician for treatment, and an antibiotic was given to the patient. At the time of reporting the patient was not recovered. Follow-up information has been received from the physician concerning the 10 year old male with asthma, penicillin allergy and sulfonamide allergy and a history of a very severe cellulitis who on 09-JUN-2009 (at 4:00 PM or so) was vaccinated into left arm with a dose of VARIVAX (Merck) (lot# 664018/0475Y, 0.5ml, subcutaneous injection). At the time of vaccination the patient was "recovering from pertussis". The patient was seen by physician and recovered on an unspecified date. No further information is available.
Age: 1.3
Sex: F
Vaccine: HIBV, PNC13
Symptoms: Erythema multiforme
Clinical narrative: Had PREVNAR 13 on 4/29/10, traveled out of town.  Woke with erythema multiforme on 5/3/10.
Age: 1.38
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect dose administered
Clinical narrative: Information has been received from a registered nurse concerning a 16 month old patient who on 18-JUN-2009 was vaccinated with a less than recommended amount dose of VARIVAX (LOT# not reported). Some of the vaccine solution leaked between the needle and the syringe during administration to the patient. No adverse event was reported. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a nurse concerning a female who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (Lot # not reported).  After approximately 6 days from vaccination, the patient developed a rash.  The patient sought medical attention by a phone call and the outcome was not provided.  The nurse stated that she was filling out a VAERS form related to this situation.  Additional information has been requested.
Age: 1.4
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Herpes simplex serology negative, Polymerase chain reaction, Varicella post vaccine, Varicella virus test positive
Clinical narrative: Information has been received from a physician concerning a 17 month old female with a history of eczema and coeliac disease who on 08-JAN-2009 was vaccinated with the first dose of VARIVAX (Merck) (subcutaneous, 0.5 ml, lot # 660669/1381X) in her right leg.  On the same day the patient also received VAQTA (MSD) (lot # 658172/0800U) and MMR II (MSD) (lot # 661724/1365X).  Five months after receiving the vaccine the patient presented with a varicella like rash on her right leg that spread up her thigh (the rash was not itchy).  The physician did a scratch test and it came back positive for varicella and negative for herpes.  The physician prescribed acyclovir and followed-up with the patient about a week ago and the patient was doing better.  The laboratory tests included PCR and DSA tests and it indicated positive for VZV. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 4 year old male who on 16-JUN-2009 was vaccinated with a dose of VARIVAX (Merck) (lot # 663536/0263Y, 0.5ml, subcutaneous injection).  Concomitant therapy included DTAP (unspecified) and IPV (unspecified) given on the same day.  On approximately 17-JUN-2009 ("within a day or 2 of the injection") the patient developed redness and warmth at the injection site.  The patient had sought medical attention.  The events improved on an unspecified date.  This is one of several reports from the same source.  Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 16 month old male who on 17-JUN-2009 was subcutaneously vaccinated with a 0.5 ml dose of VARIVAX (Merck) (lot #663541/0335Y).  Concomitant vaccination included DTAP (unspecified) and IPV (unspecified) given on the same day.  On approximately 17-JUN-2009 ("within a day or 2 of the injection") the patient developed redness and warmth at the injection site.  Subsequently, the patient recovered on an unspecified date.  The patient sought unspecified medical attention.  This is one of several reports from the same source.  Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: No therapeutic response, Varicella virus test negative
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 42 year old female patient who in 2001 was vaccinated with the first 0.5ml dose of VARIVAX (Merck) subcutaneously.  In 2002, the patient received the second 0.5ml dose of VARIVAX (Merck) (lot #635795/0778L) subcutaneously.  There were no drug reactions, allergies, other medical history and concomitant medication.  On 01-JUN-2009, the patient did the titer test, the result showed failing to seroconvert after receiving 2 doses of vaccine.  The patient had sought physician's medical attention.  Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 12 year old female patient who on 16-JUN-2009 was vaccinated with a 0.5ml dose of VARIVAX (Merck) (lot #663536/0263Y) subcutaneously.  Subsequently, one day or 2 day after injection, the patient developed "redness and warmth" at the injection site.  The patient had sought unspecified medical attention.  No lab diagnostics study was performed.  The patient recovered on an unspecified date.  This is one of several reports received from the same source.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a consumer concerning her 4 year old son who was vaccinated with VARIVAX (Merck) when he was 3 years old.  One year later, the patient developed shingles and had another case of shingles after 6 months and had another two cases of shingles again later on.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a patient who on 19-JUN-2009 was vaccinated with VARIVAX (Merck) (lot # not reported) 0.5ml, subcutaneously instead of ZOSTAVAX (Merck). No adverse effect was reported. This one of two reports from the same source. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Acne, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a registered nurse and a consumer for the Pregnancy Registry for VARIVAX (Merck) concerning the 34 year old female consumer with no known drug reaction/allergies, who on 02-JUN-2009 was vaccinated with the first dose of VARIVAX (Merck) (Lot # 654281/1890U), 0.5ml.  Concomitant therapy included prenatal vitamins (unspecified).  The consumer stated that she was 2 and half weeks pregnant after getting the first dose of VARIVAX (Merck).  The last menstrual period was 20-MAY-2009.  The estimated delivery date is 24-FEB-2010.  The patient also stated that she broke out with pimples on her face after getting the vaccine.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site urticaria
Clinical narrative: Information has been received from a physician concerning a 14 year old male with a history of contact dermatitis from neomycin who last week was vaccinated with a first does of VARIVAX (Merck). There was no concomitant medication. One hour after receiving the VARIVAX (Merck) dose the patient developed a large hive at the injection site. No laboratories studies performed. The patient sought medical attention through an office visit. The physician was unaware if any treatment required, but was able to relay that the patient fully recovered. Additional information is not expected.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 29 year old female with sulfonamide allergy who on 06-MAY-2009 was vaccinated with a 0.5 mL first dose of VARIVAX (Merck), subcutaneously. There was no concomitant medication. The patient was seen on the physician's office on 09-MAY-2009, and seven days after receiving the VARIVAX (Merck) dose, on 13-MAY-2009 the patient developed generalized vesicular rash. No laboratories studies performed. The patient recovered from generalized vesicular rash on an unspecified date without requiring treatment. Additional information is not expected.
Age: 1.05
Sex: F
Vaccine: IPV, MMR, VARCEL
Symptoms: Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a child who "last week" (on approximately 17-JUN-2009) was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number not reported). Secondary suspect vaccination included a dose of MMR II (MSD) (dose, route and lot number not reported). Other concomitant vaccination included polio vaccinination (manufacturer unknown). The registered nurse reported that the patient developed a fever as high as 103 degrees F. It was not known where in the series the patient was. The patient sought medical attention by making a phone call. Follow-up information was received from the registered nurse via a vaccine adverse experience report. It was reported that the child is 12 months old, female. Birth weight 3.7 kg, no siblings. Patient has a history of excessive crying and fever at 6 months of age, after being vaccinated with DTAP/HEP B/RV/HIB/PCV. On 09-JUN-2009 at 2:00 pm the patient received the fourth dose of PREVNAR intramuscularly on the left arm, and first dose of HAVRIX (AHAVB246AA) intramuscularly on the right arm. On 18-JUN-2009 at 5:00 pm patient was vaccinated with the first dose of VARIVAX (Merck) (lot# 657720/0358Y) subcutaneously, on the left thigh. That same date and time patient received the first dose of MMR II (MSD) (lot# 662862/1469X) (RHA) subcutaneously, on the right thigh and the third dose of IMOVAX POLIO (lot# B04752) intramuscularly on the left thigh. On 22-JUN-2009 patient developed a fever during 2 days. Highest temperature was 104.6 degrees Fahrenheit. On an unspecified date the patient completely recovered. No further information is expected.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Hepatitis B antibody negative, No therapeutic response, Varicella virus test negative
Clinical narrative: Information has been received from a consumer concerning her 17 year old daughter with asthma and no drugs allergies, who on 06-JUL-2005 was vaccinated with a first dose of VARIVAX (Merck) (lot # 649274/0896P).  The patient received a second dose of VARIVAX (Merck) (lot # 649740/0221R) on 24-AUG-2005.  Concomitant therapy included ADVIL and albuterol.  The patient failed to developed proper titers after receiving the 2 VARIVAX (Merck) doses.  The patient has no symptoms.  The patient had a blood work done on 15-JUN-2009.  It was also reported that the patient received a first dose of RECOMBIVAX HB (MSD) (lot # 643755/0706M), a second dose of RECOMBIVAX HB (MSD) (lot # 643683/0705M) and a third dose of RECOMBIVAX HB (MSD) (lot # 643366/0054N) on 11-SEP-2002, 31-OCT-2002 and on 24-JUN-2003 respectively.  The patient also failed to develop proper titers after these doses.  This is one of two reports concerning the same patient.  No further information is available.